公开(公告)号：US20220054432A1

公开(公告)日：2022-02-24

申请号：US17290992

申请日：2019-11-05

Applicant: ENEOS Corporation

Inventor： Moe KAWAMURA ,  Masahiro HAYASHI ,  Hideaki HARA ,  Shinsuke NAKAMURA ,  Takashi MAOKA

IPC: A61K31/122 ,  A23L33/10

Abstract: The present invention provides a novel composition for increasing the retention of a carotenoid in blood. More specifically, a composition for increasing the retention of a carotenoid in blood, the composition comprising one or more asymmetric carotenoids or a pharmaceutically acceptable salt thereof, is used.

公开(公告)号：US20210346315A1

公开(公告)日：2021-11-11

申请号：US17277706

申请日：2019-09-18

Applicant: ENEOS Corporation

Inventor： Moe KAWAMURA ,  Masahiro HAYASHI ,  Yuki KAWASHIMA ,  Hideaki HARA ,  Shinsuke NAKAMURA ,  Takashi MAOKA

IPC: A61K31/122 ,  A61K31/047 ,  A61P35/00

Abstract: The present invention provides a novel composition for inhibition or treatment of brain tumors or symptoms attributable thereto. More specifically, the present invention provides a composition for inhibition or treatment of brain tumors or symptoms attributable thereto, comprising one or more carotenoids selected from astaxanthin, adonirubin, adonixanthin, zeaxanthin, and a pharmaceutically acceptable salt thereof.